Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 223

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 6
Chunk 223
---
 well as insurance (unless exempted under the applicable regulations), indemnification or exculpation of directors or our Chief Executive Officer, require the approval of the compensation committee, the board of directors and our shareholders, in that order. In the case of our Chief Executive Officer, the shareholder approval must fulfill, in addition to an ordinary majority, one of the following two special majority requirements:
 

◾      at least a majority of the voting rights in the company held by non-controlling shareholders who have no conflict of interest (referred   
              to under the Companies Law as a “personal interest”) in the transaction or arrangement and who are present and voting (in          
    person or by proxy) at the general meeting, must be voted in favor of approving the transaction or arrangement (for this purpose, abstentions
                                                                 are disregarded); or                                                            
-------------------------------------------------------------------------------------------------------------------------------------------------

◾      the voting rights held by non-controlling, non-conflicted shareholders (as described in the previous bullet point) who are present   
    and voting (in person or by proxy) at the general meeting, and who vote against the transaction, do not exceed two percent of the voting
                                                             rights in the company.                                                         
--------------------------------------------------------------------------------------------------------------------------------------------
 
As described above (concerning votes related to external directors), a shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in the company or has the right to appoint the majority of the directors of the company or its general manager (chief executive officer). In addition, as it relates to the approval of related party transactions, a controlling shareholder is furthermore deemed to include any shareholder possessing 25% or more of the voting rights if no other shareholder possesses more than 50% of the voting rights.
 
If the transaction or compensation arrangement of the office holder brought for approval amends an existing arrangement, then only the approval of the audit committee or compensation committee (as appropriate) is required if that committee determines that the amendment is not material in relation to the existing arrangement.
 

Disclosure of Personal Interests of Controlling Shareholders and Approval of Certain Transactions
 
Pursuant to the Companies Law, the disclosure requirements regarding personal interests that apply to directors and executive officers also apply to a controlling shareholder of a public company. In the case of an extraordinary transaction between a public company and a controlling shareholder, or in which a controlling shareholder has a personal interest, the shareholder approval requirement—by a special majority—that applies to a compensation arrangement for the chief executive officer (as described above